AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35862389 — intervention group
Group type: EXPERIMENTAL
Intervention: 150% recommended dose of fertilizer (RDF) with planting in the second week of October
Number of subjects: 0
Study 35862389 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% recommended dose of fertilizer (RDF) with planting in the first and second week of October
Number of subjects: 0
Study 33666554 — intervention group
Group type: EXPERIMENTAL
Intervention: HealthyMoms app
Number of subjects: 19
Study 33189900 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2798745
Number of subjects: 47
Study 33189900 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 35972131 — intervention group
Group type: EXPERIMENTAL
Intervention: Medically tailored meals (MTMs)
Number of subjects: 1977
Study 33479440 — intervention group
Group type: EXPERIMENTAL
Intervention: Primed participants (immersed in a real environment with olfactory and visual cues)
Number of subjects: 49
Study 33479440 — intervention group
Group type: EXPERIMENTAL
Intervention: Primed participants
Number of subjects: 49
Study 33479440 — intervention group
Group type: EXPERIMENTAL
Intervention: Primed participants with insight
Number of subjects: 49
Study 33479440 — intervention group
Group type: COMPARATOR
Intervention: Non primed participants
Number of subjects: 49
Study 32197373 — intervention group
Group type: EXPERIMENTAL
Intervention: High sugar sweetened beverage (hiSSB) dietary pattern
Number of subjects: 101
Study 32197373 — intervention group
Group type: COMPARATOR
Intervention: Low sugar sweetened beverage (loSSB) dietary pattern
Number of subjects: 101
Study 34989804 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflibercept (2.0 mg/0.05 mL)
Number of subjects: 425
Study 34989804 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (1.25 mg/0.05 mL)
Number of subjects: 425
Study 34989804 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab (0.5 mg/0.05 mL)
Number of subjects: 425
Study 34989804 — intervention group
Group type: COMPARATOR
Intervention: Persistent ME
Number of subjects: 425
Study 34362029 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Therapy (MT)
Number of subjects: 90
Study 34362029 — intervention group
Group type: COMPARATOR
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 90
Study 36090766 — intervention group
Group type: EXPERIMENTAL
Intervention: Auriculotemporal nerve block (ANB)
Number of subjects: 40
Study 36090766 — intervention group
Group type: COMPARATOR
Intervention: Gow-Gates (GG) mandibular anesthesia
Number of subjects: 40
Study 35876254 — intervention group
Group type: EXPERIMENTAL
Intervention: Discharge planning
Number of subjects: 66
Study 35876254 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatments
Number of subjects: 66
Study 35876254 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning signs
Number of subjects: 66
Study 35876254 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 66
Study 33803694 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week CrossFit training program
Number of subjects: 30
Study 33803694 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 34644619 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity exercise training
Number of subjects: 286
Study 34644619 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate/high-intensity exercise training
Number of subjects: 286
Study 34644619 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard treatment/non-exercise)
Number of subjects: 286
Study 34767839 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulus-focused reappraisal
Number of subjects: 86
Study 34767839 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-based reappraisal
Number of subjects: 86
Study 34767839 — intervention group
Group type: COMPARATOR
Intervention: Control instruction
Number of subjects: 86
Study 35240678 — intervention group
Group type: EXPERIMENTAL
Intervention: Attended AOBP
Number of subjects: 133
Study 35240678 — intervention group
Group type: COMPARATOR
Intervention: Unattended AOBP
Number of subjects: 133
Study 35240678 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 minutes of rest
Number of subjects: 133
Study 35240678 — intervention group
Group type: COMPARATOR
Intervention: 15 minutes of rest
Number of subjects: 133
Study 35240678 — intervention group
Group type: EXPERIMENTAL
Intervention: AOBP after 5 minutes of rest
Number of subjects: 133
Study 35240678 — intervention group
Group type: COMPARATOR
Intervention: Daytime ABPM
Number of subjects: 133
Study 34674750 — intervention group
Group type: EXPERIMENTAL
Intervention: Bamlanivimab (4200 mg)
Number of subjects: 1300000
Study 34674750 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1300000
Study 32342841 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin MDA
Number of subjects: 1200
Study 32342841 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1200
Study 36187057 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone WeChat application (group A)
Number of subjects: 1428
Study 36187057 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional education plus smartphone WeChat application (group B)
Number of subjects: 1428
Study 36187057 — intervention group
Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 1428
Study 33357601 — intervention group
Group type: EXPERIMENTAL
Intervention: Values clarification exercise
Number of subjects: 93
Study 33357601 — intervention group
Group type: COMPARATOR
Intervention: Time management control condition
Number of subjects: 93
Study 33506798 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP) injection
Number of subjects: 45
Study 33506798 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid (HA) injection
Number of subjects: 45
Study 33506798 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid injection
Number of subjects: 45
Study 32588653 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-minute mindful breathing plus standard care
Number of subjects: 30
Study 32588653 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 30
Study 33573486 — intervention group
Group type: EXPERIMENTAL
Intervention: NPWT+ (Negative Pressure Wound Therapy Plus)
Number of subjects: 59
Study 33573486 — intervention group
Group type: COMPARATOR
Intervention: NPWT (Negative Pressure Wound Therapy)
Number of subjects: 59
Study 33058694 — intervention group
Group type: EXPERIMENTAL
Intervention: CRTT‐R‐WF‐Cantonese
Number of subjects: 74
Study 33058694 — intervention group
Group type: EXPERIMENTAL
Intervention: CRTT‐L‐Cantonese
Number of subjects: 74
Study 33058694 — intervention group
Group type: EXPERIMENTAL
Intervention: Cantonese Aphasia Battery
Number of subjects: 74
Study 33058694 — intervention group
Group type: EXPERIMENTAL
Intervention: CRTT‐Cantonese tests
Number of subjects: 74
Study 33058694 — intervention group
Group type: EXPERIMENTAL
Intervention: CRTT‐R‐WF‐Cantonese and CRTT‐L‐Cantonese
Number of subjects: 74
Study 35831149 — intervention group
Group type: EXPERIMENTAL
Intervention: Buddy Balloon Technique (BBT)
Number of subjects: 66
Study 35831149 — intervention group
Group type: COMPARATOR
Intervention: Buddy Wire Technique (BWT)
Number of subjects: 66
Study 33972624 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymorphic SSR markers (51 selected from 111 polymorphic primer pairs)
Number of subjects: 89
Study 33972624 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic structure analysis of C. japonica
Number of subjects: 89
Study 32529811 — intervention group
Group type: EXPERIMENTAL
Intervention: CCTA at 120 kVp
Number of subjects: 240
Study 32529811 — intervention group
Group type: EXPERIMENTAL
Intervention: CCTA at 100 kVp
Number of subjects: 240
Study 32529811 — intervention group
Group type: EXPERIMENTAL
Intervention: CCTA at 80 kVp
Number of subjects: 240
Study 32529811 — intervention group
Group type: EXPERIMENTAL
Intervention: CCTA at 70 kVp
Number of subjects: 240
Study 35315950 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-race/ethnicity expert endorsements
Number of subjects: 2117
Study 35315950 — intervention group
Group type: EXPERIMENTAL
Intervention: Different-race/ethnicity expert endorsements
Number of subjects: 2117
Study 35315950 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 2117
Study 35996467 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-way SMS intervention
Number of subjects: 294
Study 35996467 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-way SMS intervention
Number of subjects: 294
Study 35996467 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined single-way and double-way SMS
Number of subjects: 294
Study 35996467 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SMS intervention)
Number of subjects: 294
Study 33206786 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole purple grape juice (400 ml; 200 ml before and 200 ml after training)
Number of subjects: 15
Study 33206786 — intervention group
Group type: COMPARATOR
Intervention: Control group (water; 400 ml; 200 ml before and 200 ml after training)
Number of subjects: 15
Study 32520900 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal 17β estradiol (tE2) 50μg/d
Number of subjects: 78
Study 32520900 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral conjugated equine estrogen (oCEE) 0.45mg/d
Number of subjects: 78
Study 32520900 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 32613644 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Acceptance and Commitment Therapy (ACT)
Number of subjects: 42
Study 32613644 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Cognitive Behavioural Therapy (CBT)
Number of subjects: 42
Study 32118739 — intervention group
Group type: EXPERIMENTAL
Intervention: Fu's subcutaneous needling (FSN) therapy, 12 sessions over 3 weeks
Number of subjects: 80
Study 32118739 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture therapy at specified points using acupuncture needles
Number of subjects: 80
Study 32118739 — intervention group
Group type: EXPERIMENTAL
Intervention: FSN therapy
Number of subjects: 80
Study 32118739 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture therapy
Number of subjects: 80
Study 35765921 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-g intravenous TXA
Number of subjects: 149
Study 35765921 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-g intravenous TXA
Number of subjects: 149
Study 35765921 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 33583027 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose of dexamethasone (12 mg intravenously daily for up to 10 days)
Number of subjects: 1000
Study 33583027 — intervention group
Group type: COMPARATOR
Intervention: Lower dose of dexamethasone (6 mg intravenously daily for up to 10 days)
Number of subjects: 1000
Study 35459949 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracervical insemination (ICI)
Number of subjects: 421
Study 35459949 — intervention group
Group type: COMPARATOR
Intervention: Intrauterine insemination (IUI)
Number of subjects: 421
Study 34376072 — intervention group
Group type: EXPERIMENTAL
Intervention: Correction methods for attrition (specific methods not detailed)
Number of subjects: 0
Study 34376072 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation analyses
Number of subjects: 0
Study 36200652 — intervention group
Group type: EXPERIMENTAL
Intervention: CART model using PPDU, PPDI, and RGAC as predictors
Number of subjects: 132
Study 36200652 — intervention group
Group type: EXPERIMENTAL
Intervention: CART model
Number of subjects: 132
Study 33783488 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood body size
Number of subjects: 24925
Study 33783488 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariable MR accounting for adult body size
Number of subjects: 24925
Study 33783488 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood body size (specific biomarkers: leucine, isoleucine, tyrosine)
Number of subjects: 24925
Study 33783488 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-low-density lipoprotein markers
Number of subjects: 24925
Study 32291880 — intervention group
Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 521
Study 32291880 — intervention group
Group type: COMPARATOR
Intervention: iGlar
Number of subjects: 521
Study 35477419 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline & active choice (GA)
Number of subjects: 564
Study 35477419 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline & active choice & action planning (GA +)
Number of subjects: 564
Study 35477419 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline & information (GI)
Number of subjects: 564
Study 35477419 — intervention group
Group type: COMPARATOR
Intervention: Physical activity guideline only (control group G)
Number of subjects: 564
Study 32416983 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2T10I (screws tightened twice with a 10-minute interval)
Number of subjects: 50
Study 32416983 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2T0I (screws tightened twice with no interval)
Number of subjects: 50
Study 32416983 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1T (screws tightened 1 time only)
Number of subjects: 50
Study 32416983 — intervention group
Group type: EXPERIMENTAL
Intervention: Group TCT (screws tightened, counter-tightened, and then tightened again)
Number of subjects: 50
Study 32416983 — intervention group
Group type: EXPERIMENTAL
Intervention: Group TCTCT (screws tightened, counter-tightened, tightened, counter-tightened, and then tightened again)
Number of subjects: 50
Study 33609498 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodegradable polymer sirolimus-eluting stents (BP SES)
Number of subjects: 5780
Study 33609498 — intervention group
Group type: COMPARATOR
Intervention: Durable polymer everolimus-eluting stents (DP EES)
Number of subjects: 5780
Study 36271193 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment intensity (average 3.7 ± 2.6 equivalent medications at usual dosages)
Number of subjects: 1431
Study 36271193 — intervention group
Group type: EXPERIMENTAL
Intervention: Renin-angiotensin system inhibitors
Number of subjects: 1431
Study 36271193 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretics
Number of subjects: 1431
Study 36271193 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium channel blockers
Number of subjects: 1431
Study 32902785 — intervention group
Group type: EXPERIMENTAL
Intervention: Localized sub-Tenon's anesthesia (group 1)
Number of subjects: 80
Study 32902785 — intervention group
Group type: COMPARATOR
Intervention: Retrobulbar anesthesia (group 2)
Number of subjects: 80
Study 36082154 — intervention group
Group type: EXPERIMENTAL
Intervention: Handgrip-strengthening exercises (HGSE) added to conventional therapy
Number of subjects: 40
Study 36082154 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (ultrasound therapy, ice, and stretching exercises)
Number of subjects: 40
Study 32681996 — intervention group
Group type: EXPERIMENTAL
Intervention: Auto-cross-linked hyaluronic acid gel after surgery
Number of subjects: 272
Study 32681996 — intervention group
Group type: COMPARATOR
Intervention: Standard care only (control group)
Number of subjects: 272
Study 34351452 — intervention group
Group type: EXPERIMENTAL
Intervention: Volumetric modulated arc therapy (VMAT) with two small tangential subarcs
Number of subjects: 48
Study 34351452 — intervention group
Group type: COMPARATOR
Intervention: Intensity modulated radiotherapy (IMRT) with two tangential fields
Number of subjects: 48
Study 34053882 — intervention group
Group type: EXPERIMENTAL
Intervention: Spanish version of Patient Satisfaction Questionnaire (PSQ-18)
Number of subjects: 240
Study 32227754 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive strategy (initial angiography and revascularization plus guideline‐based medical therapy)
Number of subjects: 777
Study 32227754 — intervention group
Group type: COMPARATOR
Intervention: Conservative strategy (guideline‐based medical therapy alone)
Number of subjects: 777
Study 36071508 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 33535795 — intervention group
Group type: EXPERIMENTAL
Intervention: Laminar Airflow System (LAS-OR)
Number of subjects: 200
Study 33535795 — intervention group
Group type: COMPARATOR
Intervention: Conventional Turbulent Airflow System (CAS-OR)
Number of subjects: 200
Study 33535795 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (LAS and CAS)
Number of subjects: 200
Study 32750063 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Nurture Intervention (FNI)
Number of subjects: 100
Study 32750063 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 100
Study 34236906 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop haptic IOL (RayOne Trifocal RAO603F IOL)
Number of subjects: 44
Study 34236906 — intervention group
Group type: COMPARATOR
Intervention: Plate-haptic IOL (AT Lisa tri 839 MP IOL)
Number of subjects: 44
Study 33002438 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy
Number of subjects: 424
Study 33002438 — intervention group
Group type: COMPARATOR
Intervention: Salvage radiotherapy
Number of subjects: 424
Study 33917433 — intervention group
Group type: EXPERIMENTAL
Intervention: Bench press exercise with 60% one-repetition maximum (1RM) to a 10% decrease of mean bar velocity as a conditioning activity (CA)
Number of subjects: 12
Study 33917433 — intervention group
Group type: EXPERIMENTAL
Intervention: Bench press throw (BPT) with 60% 1RM
Number of subjects: 12
Study 35688724 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythritol (5 seconds pretreatment)
Number of subjects: 20
Study 35688724 — intervention group
Group type: COMPARATOR
Intervention: Sodium bicarbonate (5 seconds pretreatment)
Number of subjects: 20
Study 33385417 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous artificial gravity (cAG)
Number of subjects: 24
Study 33385417 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent artificial gravity (iAG)
Number of subjects: 24
Study 33385417 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 33030755 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg
Number of subjects: 3833
Study 33030755 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3833
Study 33030755 — intervention group
Group type: COMPARATOR
Intervention: Ustekinumab
Number of subjects: 3833
Study 33030755 — intervention group
Group type: COMPARATOR
Intervention: Etanercept
Number of subjects: 3833
Study 35667065 — intervention group
Group type: EXPERIMENTAL
Intervention: Molnupiravir, 800 mg, every 12 hours for 5 days
Number of subjects: 1433
Study 35667065 — intervention group
Group type: EXPERIMENTAL
Intervention: Molnupiravir
Number of subjects: 1433
Study 35667065 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1433
Study 34914219 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressing acupuncture therapy (PAT) combined with auricular pressure beans
Number of subjects: 50
Study 34914219 — intervention group
Group type: COMPARATOR
Intervention: Auricular pressure beans combined with drug therapy
Number of subjects: 50
Study 35661487 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-food elimination diet (FFED)
Number of subjects: 40
Study 35661487 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-food elimination diet (FFED) + amino acid-based formula (AAF)
Number of subjects: 40
Study 33400434 — intervention group
Group type: EXPERIMENTAL
Intervention: r-TMS (5 Hz, 20-minute daily session, 5 days per week, for a total of 10 sessions)
Number of subjects: 20
Study 33400434 — intervention group
Group type: COMPARATOR
Intervention: Sham r-TMS (same protocol as r-TMS)
Number of subjects: 20
Study 35379222 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain neuroscience education (PNE) and exercise intervention, 6 weekly sessions plus one review session after 1 month.
Number of subjects: 53
Study 35379222 — intervention group
Group type: COMPARATOR
Intervention: Control group received treatment as usual (TAU).
Number of subjects: 53
Study 35379222 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain neuroscience education (PNE) and exercise intervention.
Number of subjects: 53
Study 34010359 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric (ISO)
Number of subjects: 10
Study 34010359 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric (CON)
Number of subjects: 10
Study 34010359 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric (ECC)
Number of subjects: 10
Study 32381795 — intervention group
Group type: EXPERIMENTAL
Intervention: Bubble Breath Play Therapy (BBPT)
Number of subjects: 48
Study 32381795 — intervention group
Group type: COMPARATOR
Intervention: Tell-Show-Do (TSD) technique
Number of subjects: 48
Study 35246272 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-school social marketing intervention including student needs survey, health promotion council, classroom curriculum, social-marketing activities, parent information, and review of sexual health services.
Number of subjects: 6
Study 35246272 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 6
Study 35246272 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-school social marketing intervention.
Number of subjects: 6
Study 35246272 — intervention group
Group type: EXPERIMENTAL
Intervention: Linkage to birth/abortion records.
Number of subjects: 6
Study 36286651 — intervention group
Group type: COMPARATOR
Intervention: Bulevirtide monotherapy for 24 weeks (MYR202 study)
Number of subjects: 56
Study 36286651 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulevirtide monotherapy and combination with PEG‐IFN for 48 weeks (MYR203 study)
Number of subjects: 56
Study 35395819 — intervention group
Group type: EXPERIMENTAL
Intervention: Core stability training (15 min) + conventional treatment (40 min/day, 5 times/week for 8 weeks)
Number of subjects: 41
Study 35395819 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (40 min/day, 5 times/week for 8 weeks)
Number of subjects: 41
Study 33639967 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomato powder (30 mg lycopene, 5.38 mg beta-carotene, 22.32 mg phytoene, 9.84 mg phytofluene)
Number of subjects: 11
Study 33639967 — intervention group
Group type: EXPERIMENTAL
Intervention: Lycopene supplement (30 mg lycopene)
Number of subjects: 11
Study 33639967 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11